IOVA vs TAP · rev $170.7M vs rev $13.04B
Iovance Biotherapeutics Inc (IOVA) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
TAP (TAP) common stock.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
IOVA currently screens at market cap $1.89B. TAP currently screens at market cap $0.
Not investment advice. Open the IOVA and TAP stock pages for the full models.
Not investment advice.